Published in Br J Pharmacol on April 22, 2016
Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature (2002) 12.09
The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands. Nucleic Acids Res (2013) 9.61
Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial. Chest (2007) 7.49
The Concise Guide to PHARMACOLOGY 2015/16: Enzymes. Br J Pharmacol (2015) 5.96
The acute respiratory distress syndrome. J Clin Invest (2012) 5.61
Regulation of inflammatory responses by IL-17F. J Exp Med (2008) 5.56
Management of acute organophosphorus pesticide poisoning. Lancet (2008) 5.47
The Concise Guide to PHARMACOLOGY 2015/16: G protein-coupled receptors. Br J Pharmacol (2015) 4.28
Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA (1998) 4.21
IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide-induced airway neutrophilia: IL-15 as a possible trigger. J Immunol (2003) 4.13
Contribution of neutrophils to acute lung injury. Mol Med (2010) 3.59
Acetylcholine beyond neurons: the non-neuronal cholinergic system in humans. Br J Pharmacol (2008) 3.39
Endogenous IL-17 as a mediator of neutrophil recruitment caused by endotoxin exposure in mouse airways. J Immunol (2003) 2.50
Cholinergic control of inflammation. J Intern Med (2009) 2.12
The cholinergic anti-inflammatory pathway: a missing link in neuroimmunomodulation. Mol Med (2003) 2.00
Cholinergic modulation of microglial activation by alpha 7 nicotinic receptors. J Neurochem (2004) 1.99
Antishock effect of anisodamine involves a novel pathway for activating alpha7 nicotinic acetylcholine receptor. Crit Care Med (2009) 1.72
Muscarinic receptor signaling in the pathophysiology of asthma and COPD. Respir Res (2006) 1.69
Prolonged methylprednisolone treatment suppresses systemic inflammation in patients with unresolving acute respiratory distress syndrome: evidence for inadequate endogenous glucocorticoid secretion and inflammation-induced immune cell resistance to glucocorticoids. Am J Respir Crit Care Med (2002) 1.52
Speed of initial atropinisation in significant organophosphorus pesticide poisoning--a systematic comparison of recommended regimens. J Toxicol Clin Toxicol (2004) 1.45
Respiratory failure in acute organophosphorus pesticide self-poisoning. QJM (2006) 1.44
Lessons learned from the Syrian sarin attack: evaluation of a clinical syndrome through social media. Ann Intern Med (2014) 1.39
The Concise Guide to PHARMACOLOGY 2015/16: Ligand-gated ion channels. Br J Pharmacol (2015) 1.30
The mercurial nature of neutrophils: still an enigma in ARDS? Am J Physiol Lung Cell Mol Physiol (2013) 1.29
Pulmonary and extrapulmonary acute lung injury: inflammatory and ultrastructural analyses. J Appl Physiol (1985) (2005) 1.24
A review of experimental evidence linking neurotoxic organophosphorus compounds and inflammation. Neurotoxicology (2012) 1.22
Pathogenesis of indirect (secondary) acute lung injury. Expert Rev Respir Med (2011) 1.16
Nerve agent intoxication: recent neuropathophysiological findings and subsequent impact on medical management prospects. Toxicol Appl Pharmacol (2011) 1.09
Muscarinic receptor antagonists, from folklore to pharmacology; finding drugs that actually work in asthma and COPD. Br J Pharmacol (2011) 1.07
The pharmacological properties of anisodamine. J Appl Toxicol (2007) 1.03
Guidelines for treating cardiac manifestations of organophosphates poisoning with special emphasis on long QT and Torsades De Pointes. Crit Rev Toxicol (2007) 1.02
Plasticity of the murine spleen T-cell cholinergic receptors and their role in in vitro differentiation of naïve CD4 T cells toward the Th1, Th2 and Th17 lineages. Genes Immun (2011) 1.00
Role of muscarinic receptors in the regulation of immune and inflammatory responses. J Neuroimmunol (2008) 0.97
Combined administration of anisodamine and neostigmine produces anti-shock effects: involvement of α7 nicotinic acetylcholine receptors. Acta Pharmacol Sin (2012) 0.95
Anisodamine inhibits thromboxane synthesis, granulocyte aggregation, and platelet aggregation. A possible mechanism for its efficacy in bacteremic shock. JAMA (1982) 0.95
IL-17-producing T lymphocytes in lung tissue and in the bronchoalveolar space after exposure to endotoxin from Escherichia coli in vivo--effects of anti-inflammatory pharmacotherapy. Pulm Pharmacol Ther (2008) 0.94
Signal pathway involved in inhibition by lipoxin A(4) of production of interleukins induced in endothelial cells by lipopolysaccharide. Inflamm Res (2008) 0.92
The oxygen radical generator pyrogallol impairs cardiomyocyte contractile function via a superoxide and p38 MAP kinase-dependent pathway: protection by anisodamine and tetramethylpyrazine. Cardiovasc Toxicol (2004) 0.91
Expression of IL-17A and IL-17F in lipopolysaccharide-induced acute lung injury and the counteraction of anisodamine or methylprednisolone. Cytokine (2014) 0.91
Potential pharmacological strategies for the improved treatment of organophosphate-induced neurotoxicity. Can J Physiol Pharmacol (2014) 0.90
Anisodamine counteracts lipopolysaccharide-induced tissue factor and plasminogen activator inhibitor-1 expression in human endothelial cells: contribution of the NF-kappa b pathway. J Vasc Res (2001) 0.89
Cholinergic regulation of airway inflammation and remodelling. J Allergy (Cairo) (2012) 0.86
Adrenoceptor blocking properties of atropine-like agents anisodamine and anisodine on brain and cardiovascular tissues of rats. Br J Pharmacol (1986) 0.85
Immune responses in mice to arecoline mediated by lymphocyte muscarinic acetylcholine receptor. Cell Biol Int (2006) 0.85
Acute exposure to sarin increases blood brain barrier permeability and induces neuropathological changes in the rat brain: dose-response relationships. Neuroscience (2002) 0.85
Central respiratory failure during acute organophosphate poisoning. Respir Physiol Neurobiol (2013) 0.85
Differential neuropsychopharmacological influences of naturally occurring tropane alkaloids anisodamine versus scopolamine. Neurosci Lett (2008) 0.84
Acute and long-lasting cardiac changes following a single whole-body exposure to sarin vapor in rats. Toxicol Sci (2005) 0.84
Respiratory complications of organophosphorus nerve agent and insecticide poisoning. Implications for respiratory and critical care. Am J Respir Crit Care Med (2014) 0.83
New drugs derived from medicinal plants. Therapie (2002) 0.83
Vagus nerve through α7 nAChR modulates lung infection and inflammation: models, cells, and signals. Biomed Res Int (2014) 0.82
Modulatory effect of anisodamine on airway hyper-reactivity and eosinophilic inflammation in a murine model of allergic asthma. Int Immunopharmacol (2010) 0.81
Effects of combined anisodamine and neostigmine treatment on the inflammatory response and liver regeneration of obstructive jaundice rats after hepatectomy. Biomed Res Int (2014) 0.81
Combined treatment with anisodamine and neostigmine inhibits joint inflammation in collagen-induced arthritis mice. CNS Neurosci Ther (2014) 0.81
Cerebral edema induced in mice by a convulsive dose of soman. Evaluation through diffusion-weighted magnetic resonance imaging and histology. Toxicol Appl Pharmacol (2007) 0.80
Beneficial effect of anisodamine in hemorrhagic shock. Naunyn Schmiedebergs Arch Pharmacol (1984) 0.80
Anisodamine as an effective drug to treat snakebites. J Nat Toxins (1999) 0.80
Medical management of toxicological mass casualty events. Isr Med Assoc J (2008) 0.80
Role of M3 mAChR in in vivo and in vitro models of LPS-induced inflammatory response. Int Immunopharmacol (2012) 0.79
The antishock effect of anisodamine requires the upregulation of α7 nicotine acetylcholine receptors by IL-10. Life Sci (2011) 0.79
Beneficial effects of anisodamine in shock involved cholinergic anti-inflammatory pathway. Front Pharmacol (2011) 0.79
Deterioration in brain and heart functions following a single sub-lethal (0.8 LCt50) inhalation exposure of rats to sarin vapor: a putative mechanism of the long term toxicity. Toxicol Appl Pharmacol (2011) 0.79
Developments in alternative treatments for organophosphate poisoning. Toxicol Lett (2015) 0.79
Differentiating effects of anisodamine on cognitive amelioration and peripheral muscarinic side effects induced by pilocarpine in mice. Neurosci Lett (2003) 0.78
Atropine treatment modifies LPS-induced inflammatory response and increases survival. Inflamm Res (2008) 0.78
Drug development for the management of organophosphorus poisoning. Expert Opin Drug Discov (2013) 0.78
Anisodamine protects against neuronal death following cerebral ischemia in gerbils. Chin Med J (Engl) (2000) 0.78
Comparison of the inhibitory efficacy of four belladonna drugs on gastrointestinal movement and cognitive function in food-deprived mice. Pharmacology (2004) 0.78
Butyrylcholinesterase in guinea pig lung lavage: a novel biomarker to assess lung injury following inhalation exposure to nerve agent VX. Inhal Toxicol (2006) 0.78
Cardioprotective Effect of Anisodamine Against Myocardial Ischemia Injury and its Influence on Cardiomyocytes Apoptosis. Cell Biochem Biophys (2015) 0.78
Anisodamine inhibits cardiac contraction and intracellular Ca(2+) transients in isolated adult rat ventricular myocytes. Eur J Pharmacol (2002) 0.77
Interactive effects of paraoxon and pyridostigmine on blood-brain barrier integrity and cholinergic toxicity. Toxicol Sci (2004) 0.77
Anisodamine inhibits shiga toxin type 2-mediated tumor necrosis factor-alpha production in vitro and in vivo. Exp Biol Med (Maywood) (2001) 0.77
Peripheral cholinoceptor antagonist anisodamine counteracts cholinergic adverse effects and facilitates cognitive amelioration of rivastigmine. J Neural Transm (Vienna) (2009) 0.77
Arecoline inhibits interleukin-2 secretion in Jurkat cells by decreasing the expression of alpha7-nicotinic acetylcholine receptors and prostaglandin E2. J Physiol Pharmacol (2013) 0.77
Can anisodamine be a potential substitute for high-dose atropine in cases of organophosphate poisoning? Hum Exp Toxicol (2014) 0.76
Protective effect of anisodamine on respiratory function after severe brain injury. Chin J Traumatol (2002) 0.76
[Anti-arrhythmia and vegetative nervous system effects of anisodamine]. Zhongguo Yao Li Xue Bao (1991) 0.76
Anisodamine antagonizes acetylcholine-induced inhibition of adrenergic neurotransmission in the canine saphenous vein. Chin Med Sci J (1992) 0.76
Specific inhibitory action of anisodamine against a staphylococcal superantigenic toxin, toxic shock syndrome toxin 1 (TSST-1), leading to down-regulation of cytokine production and blocking of TSST-1 toxicity in mice. Clin Diagn Lab Immunol (2005) 0.76
A combination of neostigmine and anisodamine protects against ischemic stroke by activating α7nAChR. Int J Stroke (2015) 0.76
Is rivastigmine safe as pretreatment against nerve agents poisoning? A pharmacological, physiological and cognitive assessment in healthy young adult volunteers. Neurotoxicology (2015) 0.76
Effects of anisodamine on cardiovascular activities in endotoxin-shocked dogs. Chin Med J (Engl) (1984) 0.76
Protective effects of aerosolized scopolamine against soman-induced acute respiratory toxicity in guinea pigs. Int J Toxicol (2011) 0.76
Anisodamine inhibits acetylcholine-induced endothelium-dependent relaxation of canine femoral artery. Chin Med J (Engl) (1992) 0.76
Protective effect of anisodamine on cultured bovine pulmonary endothelial cell injury induced by oxygen-free radicals. Arch Surg (1992) 0.76
[Blocking effect of anisodamine on acetylcholine receptor channels]. Zhongguo Yao Li Xue Bao (1993) 0.76
Pharmacologie effects of anisodamine. Chin Med J (Engl) (1975) 0.76
Endotracheal aerosolization of atropine sulfate protects against soman-induced acute respiratory toxicity in guinea pigs. Inhal Toxicol (2011) 0.76
Non-cholinergic intervention of sarin nerve agent poisoning. Toxicology (2012) 0.76
Reduction of granulocyte-mediated lung injury in canine cardiopulmonary bypass by anisodamine infusion. Thorac Cardiovasc Surg (1991) 0.76
[Antiarrhythmic effects of anisodamine]. Yao Xue Xue Bao (1988) 0.76
Efficiency of anisodamine for organophosphorus-poisoned patients when atropinization cannot be achieved with high doses of atropine. Environ Toxicol Pharmacol (2013) 0.76
[Effects of anisodamine and scopolamine on pulmonary circulation in rabbits]. Zhongguo Yao Li Xue Bao (1986) 0.76
Comparison of current recommended regimens of atropinization in organophosphate poisoning. J Med Toxicol (2014) 0.76
Medical countermeasure against respiratory toxicity and acute lung injury following inhalation exposure to chemical warfare nerve agent VX. Toxicol Appl Pharmacol (2006) 0.76
Anisodamine inhibits non-selectively muscarinic receptors in isolated canine veins. Chin Med J (Engl) (1992) 0.75
Inhibitory effects of anisodamine on endotoxin-induced prostaglandin production by cells in culture. Chin Med J (Engl) (1988) 0.75
[Protection of anisodamine on the mitochondrial injury induced by oxidative stress in swine with cardiac arrest]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue (2013) 0.75
Quantitative analysis of anisodamine-acetylcholine antagonism in canine tracheal smooth muscle. Chin Med J (Engl) (1987) 0.75